192 related articles for article (PubMed ID: 32765671)
1. Population pharmacokinetics model and initial dose optimization of tacrolimus in children and adolescents with lupus nephritis based on real-world data.
Chen X; Wang DD; Xu H; Li ZP
Exp Ther Med; 2020 Aug; 20(2):1423-1430. PubMed ID: 32765671
[TBL] [Abstract][Full Text] [Related]
2. Optimization of initial dosing scheme of tacrolimus in pediatric refractory nephrotic syndrome patients based on CYP3A5 genotype and coadministration with wuzhi-capsule.
Chen X; Wang DD; Xu H; Li ZP
Xenobiotica; 2020 May; 50(5):606-613. PubMed ID: 31530218
[TBL] [Abstract][Full Text] [Related]
3. Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule.
Chen X; Wang D; Xu H; Li Z
J Clin Pharm Ther; 2020 Apr; 45(2):309-317. PubMed ID: 31755126
[TBL] [Abstract][Full Text] [Related]
4. Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis.
Chen L; Yang Y; Wang X; Wang C; Lin W; Jiao Z; Wang Z
Pharmgenomics Pers Med; 2021; 14():1093-1106. PubMed ID: 34511980
[TBL] [Abstract][Full Text] [Related]
5. Initial Dosage Optimization of Tacrolimus in Pediatric Patients With Thalassemia Major Undergoing Hematopoietic Stem Cell Transplantation Based on Population Pharmacokinetics.
Zhou S; Zhang R; Lv C; Lu J; Wei Y; Li C; Chen M; Li Q; Liu T
Ann Pharmacother; 2021 Apr; 55(4):440-451. PubMed ID: 32924532
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics and pharmacogenomics of tacrolimus in Chinese children receiving a liver transplant: initial dose recommendation.
Chen X; Wang DD; Xu H; Li ZP
Transl Pediatr; 2020 Oct; 9(5):576-586. PubMed ID: 33209719
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus Population Pharmacokinetic Model in Adult Chinese Patients with Nephrotic Syndrome and Dosing Regimen Identification Using Monte Carlo Simulations.
Liao M; Wang M; Zhu X; Zhao L; Zhao M
Ther Drug Monit; 2022 Oct; 44(5):615-624. PubMed ID: 36101928
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics and dosage optimisation of tacrolimus coadministration with Wuzhi capsule in adult liver transplant patients.
Du Y; Song W; Xiong X; Ge W; Zhu H
Xenobiotica; 2022 Mar; 52(3):274-283. PubMed ID: 35502774
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics and initial dose optimization of tacrolimus in children with severe combined immunodeficiency undergoing hematopoietic stem cell transplantation.
Chen X; Wang D; Zheng F; Zhai X; Xu H; Li Z
Front Pharmacol; 2022; 13():869939. PubMed ID: 35935844
[TBL] [Abstract][Full Text] [Related]
10. Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study.
Wang DD; Chen X; Li ZP
J Clin Pharm Ther; 2019 Aug; 44(4):611-617. PubMed ID: 30864229
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of tacrolimus in pediatric patients with systemic-onset juvenile idiopathic arthritis: Initial dosage recommendations.
Wang D; Chen X; Xu H; Li Z
Exp Ther Med; 2019 Dec; 18(6):4653-4660. PubMed ID: 31772640
[TBL] [Abstract][Full Text] [Related]
12. Effects of voriconazole on population pharmacokinetics and optimization of the initial dose of tacrolimus in children with chronic granulomatous disease undergoing hematopoietic stem cell transplantation.
Chen X; Wang D; Lan J; Wang G; Zhu L; Xu X; Zhai X; Xu H; Li Z
Ann Transl Med; 2021 Sep; 9(18):1477. PubMed ID: 34734029
[TBL] [Abstract][Full Text] [Related]
13. Effects of Posaconazole on Tacrolimus Population Pharmacokinetics and Initial Dose in Children With Crohn's Disease Undergoing Hematopoietic Stem Cell Transplantation.
Chen X; Wang D; Zheng F; Zhu L; Huang Y; Zhu Y; Huang Y; Xu H; Li Z
Front Pharmacol; 2022; 13():758524. PubMed ID: 35496296
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and dosage optimization of tacrolimus in pediatric patients with nephrotic syndrome
.
Wang X; Han Y; Chen C; Ma L; Xiao H; Zhou Y; Cui Y; Wang F; Su B; Yao Y; Ding J
Int J Clin Pharmacol Ther; 2019 Mar; 57(3):125-134. PubMed ID: 30663980
[TBL] [Abstract][Full Text] [Related]
15. Initial dosage optimization of ciclosporin in pediatric Chinese patients who underwent bone marrow transplants based on population pharmacokinetics.
Chen X; Yu X; Wang DD; Xu H; Li Z
Exp Ther Med; 2020 Jul; 20(1):401-408. PubMed ID: 32537004
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients.
Wang D; Chen X; Xu H; Li Z
Xenobiotica; 2020 Feb; 50(2):178-185. PubMed ID: 30938547
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics and initial dosing regimen optimization of cyclosporin in pediatric hemophagocytic lymphohistiocytosis patients.
Wang DD; Ye QF; Chen X; Xu H; Li ZP
Xenobiotica; 2020 Apr; 50(4):435-441. PubMed ID: 31382792
[TBL] [Abstract][Full Text] [Related]
18. Model extrapolation to a real-world dataset: evaluation of tacrolimus population pharmacokinetics and drug interaction in pediatric liver transplantation patients.
Wang DD; Chen X; Fu M; Zheng QS; Xu H; Li ZP
Xenobiotica; 2020 Apr; 50(4):371-379. PubMed ID: 31192749
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetics and Initial Dose Optimization of Sirolimus Improving Drug Blood Level for Seizure Control in Pediatric Patients With Tuberous Sclerosis Complex.
Chen X; Wang D; Zhu L; Lu J; Huang Y; Wang G; Zhu Y; Ye Q; Wang Y; Xu H; Li Z
Front Pharmacol; 2021; 12():647232. PubMed ID: 33995061
[TBL] [Abstract][Full Text] [Related]
20. A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.
Andrews LM; Hesselink DA; van Gelder T; Koch BCP; Cornelissen EAM; Brüggemann RJM; van Schaik RHN; de Wildt SN; Cransberg K; de Winter BCM
Clin Pharmacokinet; 2018 Apr; 57(4):475-489. PubMed ID: 28681225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
